← All organizations

Highest phase reached
Phase 3
First clinical trial
Nov 2, 1999Last known activity
Nov 30, 2025
Timeline
1990s
- Jan 1, 1997
Taiwan Liposome Company— Founded
Drugs by trial phase (9 distinct, 20 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (32)
- NCT07222748OfficialPhase 3Nov 30, 2025
- NCT07222748Lead sponsorPhase 3Nov 30, 2025
- NCT06574269OfficialPhase 2Sep 30, 2024
- NCT06574269Lead sponsorPhase 2Sep 30, 2024
- NCT05161637Lead sponsorPhase 2/Phase 3Feb 28, 2023
- NCT05161637Study directorPhase 2/Phase 3Feb 28, 2023
- NCT04697654Lead sponsorPhase 1Oct 8, 2020
- NCT04697654Study directorPhase 1Oct 8, 2020
- NCT04123561Study directorPhase 3Nov 15, 2019
- NCT04123561Lead sponsorPhase 3Nov 15, 2019
- NCT03838133Lead sponsorPhase 2Mar 5, 2019
- NCT03838133Study directorPhase 2Mar 5, 2019
- NCT03754049Lead sponsorPhase 2Jan 21, 2019
- NCT03754049Study directorPhase 2Jan 21, 2019
- NCT03591146Lead sponsorPhase 1/Phase 2Jul 31, 2018
Details
- Founded
- Taipei City, TW Jan 1, 1997
- Last known activity
- Nov 30, 2025